跳至主要内容
临床试验/DRKS00031382
DRKS00031382招募中Unknown

Transcutaneous Vagal Nerve Stimulation for the Treatment ofPersistent Atrial Fibrillation (VAST-AF): a Randomized, Controlled,Blinded, Monocentric, Clinical Trial - VAST-AF

Marienhaus Klinikum Hetzelstift0 个研究点目标入组 120 人开始时间: 2023年3月3日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Persistend atrial fibrillation
  • Planned electric cardioversion
  • Sufficient oral anticoagulation for at least four weeks or
  • Absence of thrombus in TEE
  • Oral anticoagulation possible
  • Able to sign informed consent
  • Estimated life expectancy >1 year

排除标准

  • Permanent atrial fibrillation
  • Ablation therapy of supraventricular arrhythmias in the past
  • Missing anticoagulation respective missing rule out of thrombus
  • Inability to treat with oral anticoagulation
  • Latent or manifest hyperthyroidism
  • Acute infection with relevant clinical signs (temp > 38°C, significant elevated CRP or WBC)
  • Inability to sign informed consent
  • Preexisting pacemaker or ICD
  • Recent vagal stimulation for other causes
  • Recent intolerance of transcutaneous vagal stimulation
  • Estimated life expectancy <1 year
  • Acute coronary syndrome
  • Haemodynamic instability
  • Valvular atrial fibrillation

研究者

发起方
Marienhaus Klinikum Hetzelstift

相似试验